NRG-CC013

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
NRG-CC013: A RANDOMIZED, MASKED, PLACEBO CONTROLLED, PHASE II TRIAL OF CONCURRENT CHEMORADIATION WITH BMX-001 IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CHEMORADIATION
Principal Investigator
Headshot of Jared Rex Robbins
Professor of Radiation Oncology
Protocol Number
IRB: PRO00117671
NCT: NCT06532279
Phase
Phase II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL